SURFACTANT RECYCLING IN TYPE II PNEUMOCYTES OF LUNG

Information

  • Research Project
  • 3439974
  • ApplicationId
    3439974
  • Core Project Number
    R15HL037232
  • Full Project Number
    1R15HL037232-01
  • Serial Number
    37232
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1986 - 38 years ago
  • Project End Date
    3/31/1988 - 36 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1986 - 38 years ago
  • Budget End Date
    3/31/1988 - 36 years ago
  • Fiscal Year
    1986
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -

SURFACTANT RECYCLING IN TYPE II PNEUMOCYTES OF LUNG

It has become apparent recently that pulmonary surfactant phospholipid molecules move between functional compartments within the alveolar subphase of the lung, including extensive recycling of surfactant to the type II pneumocytes. Evidence has been obtained for the existence of a protein in the alveolar subphase that catalyzes the transfer of phospholipids between artificial membranes. The projects outlined in this proposal are directed at determining whether or not this protein is a normal secretory component of type II pneumocytes and whether or not this protein can catalyze the reincorporation of surfactant phospholipids back into the type II pneumocyte for recycling. Type II pneumocytes will be isolated from rat lungs using elastase. The cells in monolayer culture will be stimulated to secrete surfactant and the medium will be examined for phospholipid transfer activity. Other experiments will involve incubation of isolated type II pneumocytes in suspension culture with a purified phospholipid transfer protein from lavage material. Vesicles of various composition will be used as donor membranes and the nature and specificity of the transfer process to the type II pneumocyte determined. An elucidation of the mechanisms controlling the movement of phospholipids between the various functional compartments of the lung is essential to understanding and eventually manipulating the pulmonary surfactant system. A clear understanding of the role of alveolar subphase proteins may be required before a fully functional artificial surfactant can be developed.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R15
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    999
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
  • Funding Mechanism
  • Study Section
    RAP
  • Study Section Name
    Respiratory and Applied Physiology Study Section
  • Organization Name
    WESTERN CAROLINA UNIVERSITY
  • Organization Department
  • Organization DUNS
  • Organization City
    CULLOWHEE
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    28723
  • Organization District
    UNITED STATES